Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
85.8M
-
Shares change
-
+14.3M
-
Total reported value, excl. options
-
$2.43B
-
Value change
-
+$415M
-
Put/Call ratio
-
0.21
-
Number of buys
-
74
-
Number of sells
-
-44
-
Price
-
$28.31
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q3 2020
146 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q3 2020.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85.8M shares
of 170M outstanding shares and own 50.38% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (21.6M shares), ARK Investment Management LLC (12.3M shares), FMR LLC (10.7M shares), BlackRock Inc. (6.02M shares), Sumitomo Mitsui Trust Holdings, Inc. (5.53M shares), Nikko Asset Management Americas, Inc. (5.53M shares), RA CAPITAL MANAGEMENT, L.P. (4.75M shares), GILDER GAGNON HOWE & CO LLC (3.19M shares), FEDERATED HERMES, INC. (2.79M shares), and VANGUARD GROUP INC (2.76M shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.